首页 > 产品 > Novel inhibitors
产品编号 产品名称 CAS No.
DC11247 Nelonicline

Nelonicline (ABT-126) is a potent, selective α7 nicotinic receptor (nAChR) partial agonist for the treatment of cognitive impairment with schizophrenia..

1026134-63-3
DC11534 Sudoterb

A novel anti-TB agent that has an MIC range of 0.06-0.5 ug/mL..

676266-31-2
DC11688 Avacopan

A potent, selective, orally availale C5aR (CD88) inhibitor with IC50 of 0.1 nM.

1346623-17-3
DC11691 NSC95397

A potent, selective, reversible Cdc25 dual specificity phosphatase inhibitor with Ki of 32/96/40 nM for Cdc25A/B/C, respectively.

93718-83-3
DC11783 UE2343(Xanamem)

UE2343 (UE-2343, Xanamem) is a potent, orally bioavailable, brain penetrant 11β-HSD1 inhibitor with IC50 of 24 nM in cell-free assays, with no activity for isozyme 11β-HSD2.

1346013-80-6
DC12074 HM30181 mesylate (Encequidar mesylate)

HM30181 mesylate is a competitive and potent P-glycoprotein inhibitor.

849675-87-2
DC12084 Pyronaridine tetraphosphate

Pyronaridine tetraphosphate is a Mannich base anti-malarial with demonstrated efficacy against drug resistant Plasmodium falciparum, P. vivax, P. ovale and P. malariae.

76748-86-2
DC12107 BI-409306

BI-409306 is a potent and selective PDE9A inhibitor, with an IC50 of 52 nM, and shows weak activity against other PDEs.

1189767-28-9
DC12131 BF-227(E/Z)

BF 227 is a candidate for an amyloid imaging probe for PET, with a Ki of 4.3 nM for Aβ1-42 fibrils.

845647-80-5
DC12191 JQ-35-(S)

JQ-35, (S)- is an inhibitor of the Bromodomain and Extra-Terminal (BET) family bromodomain-containing proteins with potential antineoplastic activity.

1349719-98-7
DC12522 MKK7-COV-3

MKK7-COV-3 (MKK7 Covalen inhibitor 3) is a potent, selective, covalent MKK7 inhibitor with in vitro IC50 of 5 nM, displays >1,000-fold selectivity over MKK4 (IC50=7.81 uM).

DC12526 OGG1 inhibitor O8

OGG1 inhibitor O8 is a potent, selective inhibitor of 8-oxoguanine DNA glycosylase 1 (OGG1) with IC50 of 0.22 uM,

350997-39-6
DC12568 UBCS039

UBCS039 (UBCS-039) is the first synthetic activator of the NAD+-dependent protein lysine deacetylase SIRT6 with EC50 of 38 uM.

358721-70-7
DC20000 LR-90

LR-90 is an advanced glycation end product (AGE) inhibitor, inhibits inflammatory responses in human monocytes. LR-90 is also used in the research of diabetic animal model.

245075-84-7
DC20332 CD38 inhibitor 78c

CD38 inhibitor 78c is a potent, specific, reversible CD38 inhibitor with Ki of 14.5 nM for recombinant human CD38.

1700637-55-3
DC20446 Mefuparib hydrochloride

Mefuparib hydrochloride is a potent, highly selective, competitive PARP1/2 inhibitor with IC50 of 3.2/1.9 nM, respectively.

1449746-00-2
DC20613 A-800141

A-800141 is a potent, highly specific, orally bioavailable MetAP2 inhibitor with IC50 of 12 nM, shows no inhibition for MetAP1 (IC50>30 uM).

681245-85-2
DC2107 Gemcitabine HCl (Gemzar,LY188011)

Gemcitabine Hydrochloride (Gemzar) is a DNA synthesis inhibitor ,showed potent activity against COVID-19(SARS-COV-2) with EC50 MERS-COV(1.216), SARS-COV(4.957).

122111-03-9
DC21158 JAK3-IN-2

A potent and highly selective JAK3 inhibitor with IC50 of 0.15 nM.

1443235-95-7
DC21396 Marizomib

A potent, orally bioactive 20S proteasome inhibitor with IC50 of 1.3 nM (inhibition of proteasomal chymotrypsin-like proteolytic activity).

437742-34-2
DC21567 Triazavirin

Triazavirin (Riamilovir sodium dihydrate) is a broad-spectrum antiviral agent targeting influenza viruses, lassa virus, TBEV and Ebola virus.

928659-17-0
DC21593 RUC-4

A potent, selective, non-RGD-mimetic αIIbβ3 integrin receptor antagonist with IC50 of 45 nM, with no activity on αVβ3 receptors. .

1448313-27-6
第 6 页 / 共 19 页第一页上一页下一页最末页转到